June 2025—Qiagen announced the launch of its QIAprep& Plasmodium kit and two companion assays to support malaria research and surveillance efforts. The solution combines sample preparation and quantitative PCR into one workflow and detects all five Plasmodium species in human samples. The QIAprep& technology detects as little as one parasite per microliter, is compatible with liquid and dried blood samples, and is suitable for use on many qPCR platforms, including the company’s Rotor-Gene Q.
The Qiagen Pf/Non-Pf detection assay is a single-reaction screen for the most common cause of malaria in humans involving Plasmodium falciparum, while the Qiagen Pv/Pm/Po/Pk detection assay helps distinguish between the remaining four common species that cause malaria—P. vivax, P. malariae, P. ovale, and P. knowlesi.
Qiagen, 0800 0229592